PF-03635659

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NamePF-03635659

Drug Alias NamePF-3635659PF-03635659

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists

TargetsMuscarinic acetylcholine receptor M3

Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveLung DiseasesRespiratory Tract Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumGermany

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesPfizer Inc

Active IndicationsN/A

Inactive IndicationsPulmonary Disease, Chronic ObstructiveLung DiseasesRespiratory Tract Diseases

ATC CodeN/A